Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses, Nat. Neurosci, vol.12, pp.1567-1576, 2009. ,
Matrix metalloproteinase-14 triggers an anti-inflammatory proteolytic cascade in endotoxemia, J. Mol. Med, vol.95, pp.487-497, 2017. ,
Cleavage of amyloid-beta precursor protein (APP) by membrane-type matrix metalloproteinases, J. Biochem, vol.139, pp.517-526, 2006. ,
Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site, J. Biol. Chem, vol.274, pp.19195-19203, 1999. ,
, Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide, pp.1-40, 1996.
, J. Neurosci, vol.16, pp.7910-7919
MT5-MMP promotes Alzheimer's pathogenesis in the frontal cortex of 5xFAD mice and APP trafficking in vitro, Front. Mol. Neurosci, vol.9, p.163, 2017. ,
Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease, Neuropharmacology, vol.126, pp.128-141, 2017. ,
MT5-MMP, just a new APP processing proteinase in Alzheimer's disease?, J. Neuroinflammation, vol.13, p.167, 2016. ,
MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease, Cell Mol. Life Sci, vol.73, pp.217-236, 2016. ,
Endogenous and synthetic MMP inhibitors in CNS physiopathology, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01718187
, Brain Res, vol.214, pp.313-351
BACE1 physiological functions may limit its use as therapeutic target for Alzheimer's disease, Trends Neurosci, vol.39, pp.158-169, 2016. ,
Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease, J. Biol. Chem, vol.288, pp.17495-17507, 2013. ,
Mechanism of Tau hyperphosphorylation involving lysosomal enzyme asparagine endopeptidase in a mouse model of brain ischemia, J. Alzheimers Dis, vol.63, pp.821-833, 2018. ,
The metalloprotease meprin beta is an alternative beta-secretase of, APP. Front. Mol. Neurosci, vol.9, p.159, 2016. ,
The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes, Nat. Neurosci, vol.15, pp.349-357, 2012. ,
MMPs in learning and memory and neuropsychiatric disorders, Cell Mol. Life. Sci, vol.76, pp.3207-3228, 2019. ,
A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo, Mol. Cell. Neurosci, vol.18, pp.503-511, 2001. ,
The metalloprotease meprin beta generates amino terminal-truncated amyloid beta peptide species, J. Biol. Chem, vol.287, pp.33304-33313, 2012. ,
Intraneuronal accumulation of C99 contributes to synaptic alterations, apathy-like behavior, and spatial learning deficits in 3xTgAD and 2xTgAD mice, Neurobiol. Aging, vol.71, pp.21-31, 2018. ,
Amyloid beta oligomers disrupt blood-CSF barrier integrity by activating matrix metalloproteinases, J. Neurosci, vol.35, pp.12766-12778, 2015. ,
Small things matter: implications of APP intracellular domain AICD nuclear signaling in the progression and pathogenesis of Alzheimer's disease, Prog. Neurobiol, vol.156, pp.189-213, 2017. ,
Presenilin endoproteolysis mediated by an aspartyl protease activity pharmacologically distinct from gamma-secretase, J. Neurochem, vol.85, pp.1563-1574, 2003. ,
Human umbilical cord plasma proteins revitalize hippocampal function in aged mice, Nature, vol.544, pp.488-492, 2017. ,
Recruitment of the Mint3 adaptor is necessary for export of the amyloid precursor protein (APP) from the Golgi complex, J. Biol. Chem, vol.288, pp.28567-28580, 2013. ,
The role of S100a9 in the pathogenesis of Alzheimer's disease: the therapeutic effects of S100a9 knockdown or knockout, Neurodegener. Dis, vol.10, pp.27-29, 2012. ,
Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration, Mol. Cell. Biol, vol.26, pp.4327-4338, 2006. ,
Physical and functional interaction between the alpha-and gamma-secretases: a new model of regulated intramembrane proteolysis, J. Cell Biol, vol.211, pp.1157-1176, 2015. ,
Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase, J. Biol. Chem, vol.272, pp.8090-8098, 1997. ,
Matrix metalloproteinases in the CNS: interferons get nervous, Cell Mol. Life Sci, vol.76, pp.3083-3095, 2019. ,
Genotype and plasma concentration of cystatin C in patients with late-onset Alzheimer disease, Dement. Geriatr. Cogn. Disord, vol.23, pp.251-257, 2007. ,
The amyloidbeta oligomer hypothesis: beginning of the third decade, J. Alzheimers Dis, vol.64, 2018. ,
Area-specific alterations of synaptic plasticity in the 5XFAD mouse model of Alzheimer's disease: dissociation between somatosensory cortex and hippocampus, PLoS One, vol.8, p.74667, 2013. ,
Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process, Physiol. Rev, vol.90, pp.465-494, 2010. ,
Learning by failing: ideas and concepts to tackle gamma-secretases in Alzheimer's disease and beyond, 2015. ,
, Annu. Rev. Pharmacol. Toxicol, vol.55, pp.419-437
Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes, Brain Res, vol.970, pp.205-213, 2003. ,
Porphyromonas gingivalis in Alzheimer's disease brains: evidence for disease causation and treatment with small-molecule inhibitors, Sci. Adv, vol.5, p.3333, 2019. ,
Matrix metalloproteinases in Alzheimer's disease and concurrent cerebral microbleeds, J. Alzheimers Dis, vol.48, pp.711-720, 2015. ,
Rhomboid proteases in human disease: mechanisms and future prospects, Biochim. Biophys. Acta Mol. Cell Res, vol.1864, issue.11, pp.2200-2209, 2017. ,
Statins: drugs for Alzheimer's disease?, J. Neural Transm, vol.112, pp.1057-1071, 2005. ,
Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation, Mol. Neurodegener, vol.8, issue.2, 2013. ,
Identification of a beta-secretase activity, which truncates amyloid beta-peptide after its presenilin-dependent generation, J. Biol. Chem, vol.278, pp.5531-5538, 2003. ,
Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.16451-16456, 2009. ,
Full-length amyloid precursor protein regulates lipoprotein metabolism and amyloid-beta clearance in human astrocytes, J. Biol. Chem, vol.293, pp.11341-11357, 2018. ,
Cholesterol and statins in Alzheimer's disease: current controversies, Exp. Neurol, vol.223, pp.282-293, 2010. ,
Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling, J. Biol. Chem, vol.276, pp.37491-37500, 2001. ,
Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A, vol.100, pp.10032-10037, 2003. ,
C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease, Sci. Rep, vol.7, p.2477, 2017. ,
Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians, Neurosci. Lett, vol.386, pp.176-178, 2005. ,
Involvement of caspases in proteolytic cleavage of Alzheimer's amyloidbeta precursor protein and amyloidogenic A beta peptide formation, Cell, vol.97, pp.395-406, 1999. ,
Cerebrovascular pathology during the progression of experimental Alzheimer's disease, Neurobiol. Dis, vol.88, pp.107-117, 2016. ,
Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease, J. Alzheimers Dis, vol.33, pp.781-796, 2013. ,
Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease, Hippocampus, vol.24, pp.762-772, 2014. ,
Snitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death, Science, vol.297, pp.1186-1190, 2002. ,
The many substrates of presenilin/gamma-secretase, J. Alzheimers Dis, vol.25, pp.3-28, 2011. ,
Trafficking and proteolytic processing of APP. Cold Spring Harb, Perspect. Med, vol.2, p.6270, 2012. ,
Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth, Cell Growth Differ, vol.12, pp.573-580, 2001. ,
Fetuin-A and cystatin C are endogenous inhibitors of human meprin metalloproteases, Biochemistry, vol.49, pp.8599-8607, 2010. ,
Neuronal TIMP-1 release accompanies astrocytic MMP-9 secretion and enhances astrocyte proliferation induced by betaamyloid 25-35 fragment, J. Neurosci. Res, vol.87, pp.2115-2125, 2009. ,
Sequential amyloid-beta degradation by the matrix metalloproteases MMP-2 and MMP-9, J. Biol. Chem, vol.290, pp.15078-15091, 2015. ,
Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells, J. Biol. Chem, vol.285, pp.27144-27158, 2010. ,
Acute function of secreted amyloid precursor protein fragment APPsalpha in synaptic plasticity, Acta Neuropathol, vol.129, pp.21-37, 2015. ,
Identification of a region of beta-amyloid precursor protein essential for its gelatinase A inhibitory activity, J. Biol. Chem, vol.278, pp.14020-14028, 2003. ,
Novel processing of beta-amyloid precursor protein catalyzed by membrane type 1 matrix metalloproteinase releases a fragment lacking the inhibitor domain against gelatinase A, Biochemistry, vol.42, pp.6514-6526, 2003. ,
Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by betaamyloid precursor protein-derived inhibitor, J. Biol. Chem, vol.283, pp.10068-10078, 2008. ,
The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis, J. Neurosci, vol.27, pp.10895-10905, 2007. ,
MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover, Cell, vol.99, pp.81-92, 1999. ,
, , 2018.
highly bioactive oligomers represent a critical minority of soluble Abeta in Alzheimer's disease brain, Acta Neuropathol, vol.136 ,
Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain, J. Biol. Chem, vol.277, pp.16278-16284, 2002. ,
Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology, Nat. Rev. Neurosci, vol.13, pp.395-406, 2012. ,
Membrane-type matrix metalloproteinases: Their functions and regulations, Matrix Biol, pp.207-223, 2015. ,
Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease, Neurobiol. Aging, vol.33, 0196. ,
Developmental regulation of membrane type-5 matrix metalloproteinase (MT5-MMP) expression in the rat nervous system, Brain Res, vol.860, pp.174-177, 2000. ,
Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo, J. Biol. Chem, vol.286, pp.27741-27750, 2011. ,
MT1-MMP cleaves Dll1 to negatively regulate Notch signalling to maintain normal B-cell development, EMBO J, vol.30, pp.2281-2293, 2011. ,
The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex, J. Neurosci, vol.30, pp.4833-4844, 2010. ,
Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate, Eur. J. Neurosci, vol.18, pp.1507-1517, 2003. ,
Cystatin C modulates cerebral beta-amyloidosis, Nat. Genet, vol.39, pp.1437-1439, 2007. ,
A death receptor 6-amyloid precursor protein pathway regulates synapse density in the mature CNS but does not contribute to Alzheimer's disease-related pathophysiology in murine models, J. Neurosci, vol.34, pp.6425-6437, 2014. ,
Mammalian plasma fetuin-B is a selective inhibitor of ovastacin and meprin metalloproteinases, Sci. Rep, vol.9, p.546, 2019. ,
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics, Nat. Rev. Drug Discov, vol.10, pp.698-712, 2011. ,
C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression, FASEB J, vol.17, pp.1951-1953, 2003. ,
Evidence that the rab5 effector APPL1 mediates APP-betaCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease, Mol. Psychiatry, vol.21, pp.707-716, 2016. ,
Alternative selection of betasite APP-cleaving enzyme 1 (BACE1) cleavage sites in amyloid beta-protein precursor (APP) harboring protective and pathogenic mutations within the abeta sequence, J. Biol. Chem, vol.291, pp.24041-24053, 2016. ,
Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice, J. Neurochem, vol.113, pp.248-261, 2010. ,
Prion fragment peptides are digested with membrane type matrix metalloproteinases and acquire enzyme resistance through Cu(2)(+)-binding, Biomolecules, vol.4, pp.510-526, 2014. ,
Absence of mechanical allodynia and Abeta-fiber sprouting after sciatic nerve injury in mice lacking membrane-type 5 matrix metalloproteinase, FEBS Lett, vol.557, pp.125-128, 2004. ,
Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons, EMBO J, vol.31, pp.3157-3168, 2012. ,
ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons, EMBO J, vol.29, pp.3020-3032, 2010. ,
Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease, Proc. Natl. Acad. Sci. U.S.A, vol.96, pp.3922-3927, 1999. ,
Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases, J. Neurosci. Res, vol.92, pp.275-286, 2014. ,
Amyloid precursor protein products concentrate in a subset of exosomes specifically endocytosed by neurons, Cell Mol. Life Sci, vol.75, pp.757-773, 2018. ,
The beta-secretase-derived C-terminal fragment of betaAPP, C99, but not Abeta, is a key contributor to early intraneuronal lesions in tripletransgenic mouse hippocampus, J. Neurosci, vol.32, pp.16243-11655, 2012. ,
Intraneuronal aggregation of the beta-CTF fragment of APP (C99) induces Abeta-independent lysosomal-autophagic pathology, Acta Neuropathol, vol.132, pp.257-276, 2016. ,
Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease, J. Biol. Chem, vol.274, pp.23426-23436, 1999. ,
Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro, Biochemistry, vol.49, pp.1127-1136, 2010. ,
Abeta34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression, Nat. Commun, vol.10, p.2240, 2019. ,
Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression, Biochemistry, vol.41, pp.3128-3136, 2002. ,
A cellular complex of BACE1 and gamma-secretase sequentially generates Abeta from its full-length precursor, J. Cell Biol, vol.218, pp.644-663, 2019. ,
Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors, Cancer Res, vol.59, pp.2570-2576, 1999. ,
Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases, J. Neurol. Sci, vol.207, pp.71-76, 2003. ,
Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease, Neurochem. Int, vol.43, pp.191-196, 2003. ,
A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor, Nat. Med, vol.6, pp.397-404, 2000. ,
Mammalian legumain -A lysosomal cysteine protease with extracellular functions, Biochimie, 2019. ,
SET protein (TAF1beta, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain, FASEB J, vol.19, pp.1905-1907, 2005. ,
Alzheimer's disease, Nat. Rev. Dis. Primers, vol.1, p.15056, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01723790
Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium, Blood, vol.105, pp.3956-3964, 2005. ,
Effects of intrahippocampal CT105, a carboxyl terminal fragment of beta-amyloid precursor protein, alone/with inflammatory cytokines on working memory in rats, J. Neurochem, vol.82, pp.234-239, 2002. ,
Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein, Neuron, vol.10, pp.243-254, 1993. ,
Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models, Nat. Genet, vol.39, pp.1440-1442, 2007. ,
A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor, Nature, vol.362, pp.839-841, 1993. ,
Glutamate receptor trafficking and protein synthesis mediate the facilitation of ltp by secreted amyloid precursor protein-alpha, J Neurosci, vol.39, pp.3188-3203, 2019. ,
The antimicrobial protection hypothesis of Alzheimer's disease, Alzheimers Dement, vol.14, pp.1602-1614, 2018. ,
Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins, J. Neurosci, vol.26, pp.2300-2312, 2006. ,
The role of APP in structural spine plasticity, Front. Mol. Neurosci, vol.10, p.136, 2017. ,
Matrix metalloproteinases and ADAMs in stroke, Cell Mol. Life Sci, vol.76, pp.3117-3140, 2019. ,
A physiological role for amyloid-beta protein:enhancement of learning and memory, J. Alzheimers Dis, vol.19, pp.441-449, 2010. ,
Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer's disease, J. Alzheimers Dis, vol.40, pp.351-357, 2014. ,
Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harb, Perspect. Med, vol.2, p.6338, 2012. ,
Not just amyloid: physiological functions of the amyloid precursor protein family, Nat. Rev. Neurosci, vol.18, pp.281-298, 2017. ,
MMPs and ADAMs in neurological infectious diseases and multiple sclerosis, Cell Mol. Life Sci, vol.76, pp.3097-3116, 2019. ,
Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?, Neurobiol. Aging, vol.120, pp.191-203, 1996. ,
APP binds DR6 to trigger axon pruning and neuron death via distinct caspases, Nature, vol.457, pp.981-989, 2009. ,
Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation, J. Neurosci, vol.26, pp.10129-10140, 2006. ,
Soluble amyloid precursor protein-alpha modulates beta-secretase activity and amyloid-beta generation, Nat. Commun, vol.3, p.777, 2012. ,
Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study, BMC Neurosci, vol.6, p.68, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00092828
Alzheimer's therapy targeting the beta-secretase enzyme BACE1: benefits and potential limitations from the perspective of animal model studies, Brain Res. Bull, vol.126, issue.2, pp.183-198, 2016. ,
BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD, 2007. ,
, Neurobiol. Dis, vol.26, pp.134-145
Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules, J. Biol. Chem, vol.272, pp.2446-2451, 1997. ,
Genetic analysis reveals that amyloid precursor protein and death receptor 6 function in the same pathway to control axonal pruning independent of beta-secretase, J. Neurosci, vol.34, pp.6438-6447, 2014. ,
Agedependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein, J. Neurosci, vol.16, pp.6732-6741, 1996. ,
Role of matrix metalloproteinases in migration and neurotrophic properties of nasal olfactory stem and ensheathing cells, Cell Transplant, vol.22, pp.993-1010, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01460477
A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons, PLoS One, vol.4, p.8289, 2009. ,
Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors, Biol. Chem, vol.385, pp.493-504, 2004. ,
Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states, Am. J. Pathol, vol.152, pp.729-741, 1998. ,
A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease, Nat Rev Neurol, vol.15, pp.73-88, 2019. ,
The physiology of the beta-amyloid precursor protein intracellular domain AICD, J. Neurochem, vol.120, pp.109-124, 2012. ,
Alternative processing of the amyloid precursor protein family by rhomboid protease RHBDL4, J. Biol. Chem, vol.291, pp.21903-21912, 2016. ,
The discovery of proteases and intramembrane proteolysis (1), Biochem. Cell Biol, vol.97, pp.265-269, 2019. ,
Membrane cholesterol as regulator of human rhomboid protease RHBDL4, J. Biol. Chem, vol.293, pp.15556-15568, 2018. ,
Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2, J. Neurosci, vol.26, pp.5347-5359, 2006. ,
Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking, FASEB J, vol.33, pp.2910-2927, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02387988
Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP, J. Biol. Chem, vol.274, pp.8925-8932, 1999. ,
, , 1999.
, Alternative, non-secretase processing of Alzheimer's beta-amyloid precursor protein during apoptosis by caspase-6 and -8, J. Biol. Chem, vol.274, pp.21011-21016
Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease, Acta Neuropathol, vol.125, pp.201-213, 2013. ,
Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal, J. Neurosci, vol.25, pp.4917-4929, 2005. ,
sAbetaPPalpha is a Potent Endogenous Inhibitor of BACE1, J. Alzheimers Dis, vol.47, pp.545-555, 2015. ,
MT5-MMP regulates adult neural stem cell functional quiescence through the cleavage of N-cadherin, Nat. Cell Biol, vol.16, pp.629-638, 2014. ,
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model, J. Clin. Invest, vol.113, pp.1456-1464, 2004. ,
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease, Brain Res. Mol. Brain Res, vol.118, pp.140-146, 2003. ,
, , 2019.
, C99, not beta-amyloid, is associated with selective death of vulnerable neurons in Alzheimer's disease
LTP and memory impairment caused by extracellular Abeta and Tau oligomers is APP-dependent, vol.6, p.26991, 2017. ,
Endogenous amyloid-beta is necessary for hippocampal synaptic plasticity and memory, Ann. Neurol, vol.69, pp.819-830, 2011. ,
Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus, J. Neurosci, vol.28, pp.14537-14545, 2008. ,
Hormetic effect of amyloid-beta peptide in synaptic plasticity and memory, Neurobiol. Aging, vol.33, pp.15-1484, 1484. ,
Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer's disease: evidence for a pro-amyloidogenic role of MT1-MMP. Front, Aging Neurosci, vol.6, p.247, 2014. ,
Membrane trafficking pathways in Alzheimer's disease, Traffic, vol.13, pp.759-770, 2012. ,
The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition, Biochem. J, vol.411, pp.433-439, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00478897
Synaptic autoregulation by metalloproteases and gamma-secretase, 2011. ,
, J. Neurosci, vol.31, pp.12083-12093
Secreted amyloid-beta precursor protein functions as a GABABR1a ligand to modulate synaptic transmission, Science, vol.363, p.4827, 2019. ,
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology, J. Clin. Invest, vol.114, pp.121-130, 2004. ,
Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders, Cell Mol. Life Sci, vol.76, pp.3167-3191, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02387963
Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?, J. Neurosci, vol.30, pp.15337-15357, 2010. ,
Gelatinase B and TIMP-1 are regulated in a cell-and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia, Eur. J. Neurosci, vol.15, pp.19-32, 2002. ,
Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response, J. Neurosci, vol.17, pp.4223-4235, 1997. ,
Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A, Biochem. Biophys. Res. Commun, vol.205, pp.1755-1761, 1994. ,
Transient increase in sAPPalpha secretion in response to Abeta1-42 oligomers: an attempt of neuronal self-defense?, Neurobiol. Aging, vol.61, pp.23-35, 2018. ,
Cytoplasmic tail of MT1-MMP regulates macrophage motility independently from its protease activity, Genes Cells, vol.14, pp.617-626, 2009. ,
Restricted location of PSEN2/gamma-secretase determines substrate specificity and generates an intracellular Abeta pool, Cell, vol.166, pp.193-208, 2016. ,
Development and characterization of a novel membrane assay for full-length BACE-1 at pH 6.0, J. Biomol. Screen, vol.18, pp.277-285, 2013. ,
Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP), FEBS Lett, vol.385, pp.238-240, 1996. ,
Regulation of the alternative beta-secretase meprin beta by ADAMmediated shedding, Cell Mol. Life Sci, vol.76, pp.3193-3206, 2019. ,
Dipeptidyl-peptidase activity of meprin beta links N-truncation of Abeta with Glutaminyl Cyclase-Catalyzed pGlu-Abeta formation, J. Alzheimers Dis, vol.66, pp.359-375, 2018. ,
Generation of aggregation prone N-terminally truncated amyloid beta peptides by meprin beta depends on the sequence specificity at the cleavage site, Mol. Neurodegener, vol.11, p.19, 2016. ,
Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain-specific MMP highly expressed in cerebellum, Eur. J. Neurosci, vol.13, pp.935-948, 2001. ,
The amyloid hypothesis of Alzheimer's disease at 25 years, EMBO Mol. Med, vol.8, pp.595-608, 2016. ,
Beta-secretase cleavage at amino acid residue 34 in the amyloid beta peptide is dependent upon gamma-secretase activity, J. Biol. Chem, vol.278, pp.21286-21294, 2003. ,
Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons, J. Neurosci, vol.16, pp.899-908, 1996. ,
Plasma fetuin-A is associated with the severity of cognitive impairment in mild-to-moderate Alzheimer's disease, J. Alzheimers Dis, vol.24, pp.327-333, 2011. ,
Behavioral and neuropathologic changes induced by central injection of carboxyl-terminal fragment of beta-amyloid precursor protein in mice, J. Neurochem, vol.71, pp.875-878, 1998. ,
The amyloidogenic pathway of amyloid precursor protein (APP) is independent of its cleavage by caspases, J. Biol. Chem, vol.276, pp.29045-29050, 2001. ,
The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system, J. Neurochem, vol.143, pp.11-29, 2017. ,
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide, PLoS One, vol.5, p.9505, 2010. ,
Netrin-1 interrupts amyloid-beta amplification, increases sabetappalpha in vitro and in vivo, and improves cognition in a mouse model of Alzheimer's disease, J. Alzheimers Dis, vol.52, pp.223-242, 2016. ,
Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16, J. Biol. Chem, vol.287, pp.5848-5860, 2012. ,
Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease, J. Biol. Chem, vol.270, pp.5331-5338, 1995. ,
CRISPR/Cas9 editing of APP C-terminus attenuates beta-cleavage and promotes alpha-cleavage, Nat. Commun, vol.10, p.53, 2019. ,
Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates, Proc. Natl. Acad. Sci. U.S.A, vol.101, pp.6917-6922, 2004. ,
Lentivirus-mediated expression of human secreted amyloid precursor protein-alpha prevents development of memory and plasticity deficits in a mouse model of Alzheimer's disease, Mol. Brain, vol.11, p.7, 2018. ,
MMP-7 cleaves amyloid beta fragment peptides and copper ion inhibits the degradation, Biometals, vol.30, pp.797-807, 2017. ,
Dual role of alpha-secretase cleavage in the regulation of gamma-secretase activity for amyloid production, J. Biol. Chem, vol.285, pp.32549-32556, 2010. ,
Matrix metalloproteinase signals following neurotrauma are right on cue, Cell Mol. Life Sci, vol.76, pp.3141-3156, 2019. ,
Cytoplasmic taildependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity, J. Cell Biol, vol.155, pp.1345-1356, 2001. ,
Endo-lysosomal dysregulations and late-onset Alzheimer's disease: impact of genetic risk factors, Mol. Neurodegener, vol.14, p.20, 2019. ,
The genetic landscape of Alzheimer disease: clinical implications and perspectives, Genet. Med, vol.18, pp.421-430, 2016. ,
Cellular functions of the amyloid precursor protein from development to dementia, Dev. Cell, vol.32, pp.502-515, 2015. ,
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science, vol.286, pp.735-741, 1999. ,
Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects, J. Neurochem, vol.130, pp.4-28, 2014. ,
Meprin proteolytic complexes at the cell surface and in extracellular spaces, Biochem. Soc. Symp, vol.70, pp.53-63, 2003. ,
Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes, Int. J. Mol. Sci, vol.13, pp.2893-2917, 2012. ,
Mint-3 regulates the retrieval of the internalized membrane-type matrix metalloproteinase, MT5-MMP, to the plasma membrane by binding to its carboxyl end motif EWV, J. Biol. Chem, vol.279, pp.20461-20470, 2004. ,
Shedding of membrane type matrix metalloproteinase 5 by a furin-type convertase: a potential mechanism for down-regulation, J. Biol. Chem, vol.276, pp.35953-35960, 2001. ,
Expression, purification and characterization of recombinant mouse MT5-MMP protein products, FEBS Lett, vol.462, pp.261-266, 1999. ,
Modifications and trafficking of app in the pathogenesis of Alzheimer's disease, Front. Mol. Neurosci, vol.10, p.294, 2017. ,
Human brain-derived Abeta oligomers bind to synapses and disrupt synaptic activity in a manner that requires APP, J. Neurosci, vol.37, pp.11947-11966, 2017. ,
MT5-MMP, ADAM-10, and N-cadherin act in concert to facilitate synapse reorganization after traumatic brain injury, J. Neurotrauma, vol.29, pp.1922-1940, 2012. ,
Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases, J. Biol. Chem, vol.274, pp.5823-5829, 1999. ,
Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity, J. Biol. Chem, vol.281, pp.17670-17680, 2006. ,
Structure and synaptic function of metal binding to the amyloid precursor protein and its proteolytic fragments, Front. Mol. Neurosci, vol.10, p.21, 2017. ,
eta-Secretase processing of APP inhibits neuronal activity in the hippocampus, Nature, vol.526, pp.443-447, 2015. ,
Neurogenesis in gerbil hippocampus following brain ischemia: focus on the involvement of metalloproteinases, Acta Neurobiol. Exp, vol.69, pp.52-61, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00417424
Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis, J. Neurochem, vol.129, pp.559-572, 2014. ,
Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ, J. Biol. Chem, vol.281, pp.24566-24574, 2006. ,
Physiological functions of the beta-site amyloid precursor protein cleaving enzyme 1 and 2, Front. Mol. Neurosci, vol.10, p.97, 2017. ,
Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism, J. Neurosci, vol.26, pp.10939-10948, 2006. ,
Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer's disease, Nat. Commun, vol.8, p.14740, 2017. ,
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease, Nat. Med, vol.20, pp.1254-1262, 2014. ,
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease, Nat. Commun, vol.6, p.8762, 2015. ,
The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo, J. Biol. Chem, vol.287, pp.25927-25940, 2012. ,